Irish patients excluded from drug trials for life-saving treatments due to barriers
Ireland attracting fewer clinical trials than some European countries
Ireland slow to approve cancer medicines for patient use
Just half of 41 cancer drugs approved from 2017-2020 were available here at end of 2021
Ireland an outlier without access to new cell and gene therapy, report says
Upfront costs high but treatments may cut long-term expense and boost patient results
EU faces global criticism over vaccine export restrictions
Canada, Japan and South Korea warn against grab for vaccine supplies
A lot on the table as Big Pharma prepares to sit down with State over medicines
State’s lack of a clear budget structure for medicines is a frustration for Big Pharma
Calls for new government to give faster access to life-saving drugs
Pharma group says eight cancer therapies awaiting HSE approval for over 900 days
Call on Harris to focus on supply of medicines after Brexit
Companies say they are working actively to prepare for worst-case Brexit scenario
Big Pharma bids to build bridges in Ireland
Irish industry’s chief looks for partnership as he admits trust is lacking
Call for fresh approach to funding new medicines
Pharmaceutical sector urges faster access to markets and sharper focus on innovation
Pharma body calls for more State funding on medicines
Government to save €15m this year as prices fall across 750 drugs
Price pressure keeps nine new drugs from Irish patients
Cancer drugs feature in list of therapies waiting HSE approval on cost grounds
Crunch meeting fails to agree funding for new medicines
Drug companies told there is no budget and no plans for supplementary health budget
Patients suffer as new drugs languish on Minister’s desk
Cantillon: while Orkambi has been approved, nine other vital drugs are stalled in system
Pfizer bounces back from Allergan setback by buying, buying, buying
The drug giant’s point man in Ireland talks about acquisitions, setbacks, prices and Trump
Pfizer cuts price of Enbrel to match rival ‘biosimilar’ drug
Price drop is first under pricing deal signed by Government and Irish Pharmaceutical Healthcare Association
Price deal on medicines to save State €140m in first year
Annual savings of €78.4m predicted as result of agreement with drugs manufacturers
Biosimilar drugs win backing in landmark patient study
Drug manufacturers’ lobby group Ipha urges caution over study of competing treatments
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices